Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH

Documenti analoghi

• Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH
  di: Lu, Ying, et al.
  Pubblicazione: (2019)
• GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
  di: Alkhouri, Naim, et al.
  Pubblicazione: (2019)
• The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model
  di: Liu, Linfu, et al.
  Pubblicazione: (2020)
• Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
  di: Ross, Trenton T., et al.
  Pubblicazione: (2020)
• Regulation of acetyl-coA carboxylase: properties of coA activation of acetyl-coA carboxylase.
  di: Yeh, L A, et al.
  Pubblicazione: (1980)